ALMIB.PA
Amoéba S.A. [ALMIB.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALMIB.PA Stock Summary
Top 10 Correlated ETFs
ALMIB.PA
Top 10 Correlated Stocks
ALMIB.PA
In the News
ALMIB.PA Financial details
Company Rating
Neutral
Market Cap
18.95M
Income
-15.67M
Revenue
0
Book val./share
0.14
Cash/share
0.06
Dividend
-
Dividend %
-
Employees
22
Optionable
No
Shortable
Yes
Earnings
25 Mar 2024
P/E
-1.6
Forward P/E
-
PEG
-0.13
P/S
-
P/B
1.63
P/C
6.92
P/FCF
-4.16
Quick Ratio
1.33
Current Ratio
1.71
Debt / Equity
0.1
LT Debt / Equity
0.07
-
-
EPS (TTM)
-0.53
EPS next Y
-
EPS next Q
-
EPS this Y
20.83%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.62%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
13.9%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-67%
ROE
-198%
ROC
-0.71%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.365-0.704
52W High
-
52W Low
-
RSI
54
Rel Volume
0.36
Avg Volume
148.83K
Volume
53.99K
Perf Week
6.96%
Perf Month
-9.29%
Perf Quarter
4.27%
Perf Half Y
-5.68%
-
-
-
-
Beta
-0.021
-
-
Volatility
0.01%, 0.02%
Prev Close
1.22%
Price
0.415
Change
5.06%
ALMIB.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.02 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.92 | -0.5 | -0.44 | -0.24 | 0 | |
| Operating cash flow per share | -0.46 | -0.21 | -0.33 | -0.16 | 0 | |
| Free cash flow per share | -0.47 | -0.22 | -0.34 | -0.17 | 0 | |
| Cash per share | 0.6 | 0.31 | 0.41 | 0.16 | 0 | |
| Book value per share | 0.54 | 0.12 | 0.01 | 0.24 | 0 | |
| Tangible book value per share | 0.22 | -0.03 | -0.13 | 0.17 | 0 | |
| Share holders equity per share | 0.54 | 0.12 | 0.01 | 0.24 | 0 | |
| Interest debt per share | 1.28 | 0.63 | 0.83 | 0.13 | 0 | |
| Market cap | 4.14M | 50.56M | 18.85M | 28.53M | 0 | |
| Enterprise value | 7.89M | 54.2M | 24.07M | 25.36M | 0 | |
| P/E ratio | -0.57 | -6.2 | -2.41 | -3.56 | 0 | |
| Price to sales ratio | 33.8 | 0 | 0 | 0 | 0 | |
| POCF ratio | -1.14 | -14.62 | -3.19 | -5.28 | 0 | |
| PFCF ratio | -1.12 | -14.37 | -3.12 | -5 | 0 | |
| P/B Ratio | 0.98 | 25.27 | 94.88 | 3.49 | 0 | |
| PTB ratio | 0.98 | 25.27 | 94.88 | 3.49 | 0 | |
| EV to sales | 64.42 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -2.12 | -10.45 | -4.55 | -4.79 | 0 | |
| EV to operating cash flow | -2.17 | -15.68 | -4.08 | -4.69 | 0 | |
| EV to free cash flow | -2.13 | -15.4 | -3.98 | -4.44 | 0 | |
| Earnings yield | -1.75 | -0.16 | -0.41 | -0.28 | 0 | |
| Free cash flow yield | -0.9 | -0.07 | -0.32 | -0.2 | 0 | |
| Debt to equity | 1.99 | 4.07 | 61.55 | 0.29 | 0 | |
| Debt to assets | 0.61 | 0.62 | 0.84 | 0.19 | 0 | |
| Net debt to EBITDA | -1.01 | -0.7 | -0.99 | 0.6 | 0 | |
| Current ratio | 0.66 | 2.97 | 0.61 | 1.71 | 0 | |
| Interest coverage | -3.57 | -3.12 | -2.47 | -3.3 | -28.08 | |
| Income quality | 0.5 | 0.42 | 0.75 | 0.67 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 10.2 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.18 | 0.19 | 0.17 | 0.2 | 0 | |
| Capex to operating cash flow | 0.02 | 0.02 | 0.02 | 0.06 | 0 | |
| Capex to revenue | -0.6 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.03 | -0.04 | -0.17 | -0.3 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.33 | 1.18 | 0.33 | 1.14 | 0 | |
| ROIC | -0.44 | -0.59 | -0.45 | -0.57 | 0 | |
| Return on tangible assets | -0.64 | -0.77 | -0.65 | -0.81 | 0 | |
| Graham Net | -0.5 | -0.34 | -0.36 | 0.06 | 0 | |
| Working capital | -3.22M | 4.12M | -5.3M | 2.97M | 0 | |
| Tangible asset value | 1.72M | -488.75K | -2.28M | 5.68M | 0 | |
| Net current asset value | -3.44M | -4.84M | -5.85M | 2.9M | 0 | |
| Invested capital | 1.99 | 4.07 | 61.55 | 0.29 | 0 | |
| Average receivables | 559.52K | 954.8K | 785.89K | 760.23K | 0 | |
| Average payables | 195.12K | 390.33K | 434.54K | 415.75K | 0 | |
| Average inventory | 43.53K | 95.52K | 178.54K | 271.09K | 0 | |
| Days sales outstanding | 3.33K | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 60.52 | 97.35 | 203.16 | 127.3 | 0 | |
| Days of inventory on hand | 13.46 | 25.98 | 107.39 | 104.26 | 0 | |
| Receivables turnover | 0.11 | 0 | 0 | 0 | 0 | |
| Payables turnover | 6.03 | 3.75 | 1.8 | 2.87 | 0 | |
| Inventory turnover | 27.11 | 14.05 | 3.4 | 3.5 | 0 | |
| ROE | -1.71 | -4.08 | -39.35 | -0.98 | 0 | |
| Capex per share | -0.01 | 0 | -0.01 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.25 | -0.18 | -0.2 | -0.07 | -0.08 | |
| Operating cash flow per share | -0.15 | -0.18 | -0.16 | -0.04 | -0.05 | |
| Free cash flow per share | -0.15 | -0.18 | -0.16 | -0.04 | -0.07 | |
| Cash per share | 0.41 | 0.37 | 0.11 | 0.12 | 0.06 | |
| Book value per share | 0.07 | 0.01 | 0.15 | 0.18 | 0.14 | |
| Tangible book value per share | -0.08 | -0.12 | 0.05 | 0.12 | 0.08 | |
| Share holders equity per share | 0.07 | 0.01 | 0.15 | 0.18 | 0.14 | |
| Interest debt per share | 0.77 | 0.67 | 0.26 | 0.06 | 0.02 | |
| Market cap | 27.5M | 20.92M | 12.69M | 39.36M | 27.82M | |
| Enterprise value | 32.41M | 26.14M | 14.72M | 36.19M | 25.35M | |
| P/E ratio | -1.65 | -1.43 | -0.67 | -2.98 | -1.74 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -11.37 | -6.01 | -3.38 | -23.96 | -12.51 | |
| PFCF ratio | -11.09 | -5.86 | -3.34 | -20.59 | -7.83 | |
| P/B Ratio | 24.46 | 105.28 | 3.48 | 4.82 | 4.15 | |
| PTB ratio | 24.46 | 105.28 | 3.48 | 4.82 | 4.15 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -12.05 | -10.04 | -5.77 | -13.28 | -6.13 | |
| EV to operating cash flow | -13.39 | -7.51 | -3.92 | -22.03 | -11.4 | |
| EV to free cash flow | -13.07 | -7.33 | -3.88 | -18.93 | -7.13 | |
| Earnings yield | -0.15 | -0.17 | -0.37 | -0.08 | -0.14 | |
| Free cash flow yield | -0.09 | -0.17 | -0.3 | -0.05 | -0.13 | |
| Debt to equity | 9.98 | 61.55 | 1.31 | 0.29 | 0.1 | |
| Debt to assets | 0.79 | 0.84 | 0.49 | 0.19 | 0.06 | |
| Net debt to EBITDA | -1.83 | -2.01 | -0.8 | 1.16 | 0.6 | |
| Current ratio | 2.13 | 0.61 | 0.72 | 1.71 | 1.29 | |
| Interest coverage | -2.24 | -2.8 | -2.01 | -8.77 | -38.68 | |
| Income quality | 0.58 | 0.95 | 0.8 | 0.5 | 0.56 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.17 | 0.17 | 0.26 | 0.2 | 0.23 | |
| Capex to operating cash flow | 0.02 | 0.02 | 0.01 | 0.16 | 0.6 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.11 | -0.25 | -0.07 | -0.59 | -2.62 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.63 | 0.2 | 0.82 | 0.53 | 0.5 | |
| ROIC | -0.23 | -0.22 | -0.34 | -0.28 | -0.53 | |
| Return on tangible assets | -0.35 | -0.3 | -0.65 | -0.33 | -0.48 | |
| Graham Net | -0.36 | -0.32 | -0.1 | 0.04 | 0 | |
| Working capital | 4.17M | -5.3M | -1.67M | 2.97M | 1.09M | |
| Tangible asset value | -1.36M | -2.28M | 1.16M | 5.68M | 4.14M | |
| Net current asset value | -5.31M | -5.85M | -1.87M | 2.9M | 592.59K | |
| Invested capital | 9.98 | 61.55 | 1.31 | 0.29 | 0.1 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 45.52 | 125.75 | 40.18 | 69.75 | 120.47 | |
| Days of inventory on hand | 27.86 | 66.47 | 41.63 | 57.13 | 39.99 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 1.98 | 0.72 | 2.24 | 1.29 | 0.75 | |
| Inventory turnover | 3.23 | 1.35 | 2.16 | 1.58 | 2.25 | |
| ROE | -3.71 | -18.36 | -1.3 | -0.4 | -0.6 | |
| Capex per share | 0 | 0 | 0 | -0.01 | -0.03 |
ALMIB.PA Frequently Asked Questions
What is Amoéba S.A. stock symbol ?
Amoéba S.A. is a FR stock and trading under the symbol ALMIB.PA
What is Amoéba S.A. stock quote today ?
Amoéba S.A. stock price is $0.415 today.
Is Amoéba S.A. stock public?
Yes, Amoéba S.A. is a publicly traded company.
Company Profile
- Volume Average 148.83K
- Market Capitalization 18.95M
- Employee 22
- CEO Mr. Fabrice Plasson
- Headquarters Chassieu,FR
- IPO Date 2015-07-10
-
Website
https://amoeba-nature.com 
Amoéba S.A. develops and sells biocidal and fungicide products. It is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds, and plant protection. The company was founded in 2010 and is headquartered in Chassieu, France.
